tiprankstipranks
Trending News
More News >
IRLAB Therapeutics AB Class A (DE:6IRA)
BERLIN:6IRA
Advertisement

IRLAB Therapeutics AB Class A (6IRA) Revenue

Compare
1 Followers

IRLAB Therapeutics AB Class A Revenue

IRLAB Therapeutics AB Class A had a revenue of 19.53M in the quarter ending Jun 30, 2025, with 347.98%. This bring the company's revenue in the last twelve months to 75.74M, Increased -23.48%. In the fiscal year ending Dec 31, 2024, IRLAB Therapeutics AB Class A had annual revenue of 94.63M with 1566.57% growth.
Revenue (ttm)
75.74M
Revenue Growth
P/S Ratio
0.24
Revenue/Employee
€3,052,516
Employees
31
Market Cap
€22.72M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
94.63M88.95M+1,566.57%
Dec 31, 2023
5.68M-55.46M-90.71%
Dec 31, 2022
61.14M-146.65M-70.58%
Dec 31, 2021
207.78M207.48M+69,160.67%
Dec 31, 2020
300.00K274.00K+1,053.85%
Dec 31, 2019
26.00K8.00K+44.44%
Dec 31, 2018
18.00K-91.00K-83.49%
Dec 31, 2017
109.00K-35.00K-24.31%
Dec 31, 2016
144.00K
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis